3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors

Details for Australian Patent Application No. 2009289784 (hide)

Owner Addex Pharma S.A. OrthoMcNeil-Janssen Pharmaceuticals, Inc

Inventors Cid-Nunez, Jose Maria; TrabancoSuarez, Andres Avelino

Agent Davies Collison Cave

Pub. Number AU-B-2009289784

PCT Pub. Number WO2010/025890

Priority 08163517.9 02.09.08 EP

Filing date 1 September 2009

Wipo publication date 11 March 2010

Acceptance publication date 22 March 2012

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4412 (2006.01) - having oxo groups directly attached to the heterocyclic ring

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

10 March 2011 PCT application entered the National Phase

  PCT publication WO2010/025890 Priority application(s): WO2010/025890

22 March 2012 Application Accepted

  Published as AU-B-2009289784

19 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009289793-Childproof individual dose packaging for transdermal therapeutic systems or film-like forms of administration

2009289776-Pharmaceutical combination of 3- (3-Dimethylamino-1-ethyl-2 - methyl-propyl) - phenol and an antiepileptic